AAAAAA

   
Results: 1-17 |
Results: 17
METABOLIC SYNDROME AND HYPERTENSION - PATHOPHYSIOLOGY AND MOLECULAR-BASIS OF INSULIN-RESISTANCE
Authors: MULLERWIELAND D KOTZKA J KNEBEL B KRONE W
Citation: D. Mullerwieland et al., METABOLIC SYNDROME AND HYPERTENSION - PATHOPHYSIOLOGY AND MOLECULAR-BASIS OF INSULIN-RESISTANCE, Basic research in cardiology, 93, 1998, pp. 131-134
REGULATION OF THE LDL RECEPTOR GENE-EXPRESSION BY HORMONES
Authors: STREICHER R KOTZKA J MULLERWIELAND D KRONE W
Citation: R. Streicher et al., REGULATION OF THE LDL RECEPTOR GENE-EXPRESSION BY HORMONES, Zeitschrift fur Ernahrungswissenschaft, 37, 1998, pp. 85-87
IDENTIFICATION OF MUTATIONS OF THE ARGININE VASOPRESSIN-NEUROPHYSIN-II GENE IN 2 KINDREDS WITH FAMILIAL CENTRAL DIABETES-INSIPIDUS
Authors: HEPPNER C KOTZKA J BULLMANN C KRONE W MULLERWIELAND D
Citation: C. Heppner et al., IDENTIFICATION OF MUTATIONS OF THE ARGININE VASOPRESSIN-NEUROPHYSIN-II GENE IN 2 KINDREDS WITH FAMILIAL CENTRAL DIABETES-INSIPIDUS, The Journal of clinical endocrinology and metabolism, 83(2), 1998, pp. 693-696
AN ASSOCIATION BETWEEN NIDDM AND A GAA TRINUCLEOTIDE REPEAT POLYMORPHISM IN THE X25 FRATAXIN (FRIEDREICHS ATAXIA) GENE/
Authors: RISTOW M GIANNAKIDOU E HEBINCK J BUSCH K VORGERD M KOTZKA J KNEBEL B MUELLERBERGHAUS J EPPLEN C PFEIFFER A KAHN CR DORIA A KRONE W MUELLERWIELAND D
Citation: M. Ristow et al., AN ASSOCIATION BETWEEN NIDDM AND A GAA TRINUCLEOTIDE REPEAT POLYMORPHISM IN THE X25 FRATAXIN (FRIEDREICHS ATAXIA) GENE/, Diabetes, 47(5), 1998, pp. 851-854
ROLE OF THE TRANSCRIPTION FACTORS SREBP-1 AND SREBP-2 IN THE REGULATION OF THE LDL RECEPTOR (LDLR) GENE BY INSULIN AND GROWTH-FACTORS
Authors: ROTH G KOTZKA J MEYER HE MUNCK M MULLERWIELAND D KRONE W
Citation: G. Roth et al., ROLE OF THE TRANSCRIPTION FACTORS SREBP-1 AND SREBP-2 IN THE REGULATION OF THE LDL RECEPTOR (LDLR) GENE BY INSULIN AND GROWTH-FACTORS, Diabetes, 47, 1998, pp. 283-283
POSTRECEPTOR DEFECTS IN PATIENTS WITH SYNDROMES OF INSULIN-RESISTANCE- GENE-THERAPY IN CULTURED-CELLS
Authors: KNEBEL B KOTZKA J AVCI H SCHILLER M ZYMNY S KRONE W MULLERWIELAND D
Citation: B. Knebel et al., POSTRECEPTOR DEFECTS IN PATIENTS WITH SYNDROMES OF INSULIN-RESISTANCE- GENE-THERAPY IN CULTURED-CELLS, Diabetes, 47, 1998, pp. 667-667
AN ASSOCIATION BETWEEN TYPE-2 DIABETES-MELLITUS (NIDDM) AND A GAA TRINUCLEOTIDE REPEAT POLYMORPHISM IN THE FRATAXIN (FRIEDREICH ATAXIA) GENE
Authors: RISTOW M GIANNAKIDOU E HEBINCK J BUSCH K VORGERD M KOTZKA J KNEBEL B EPPLEN C PFEIFFER A DORIA A KRONE W MUELLERWIELAND D
Citation: M. Ristow et al., AN ASSOCIATION BETWEEN TYPE-2 DIABETES-MELLITUS (NIDDM) AND A GAA TRINUCLEOTIDE REPEAT POLYMORPHISM IN THE FRATAXIN (FRIEDREICH ATAXIA) GENE, Diabetes, 47, 1998, pp. 686-686
SIGNALING SPECIFICITY OF INSULIN AND EGF MEDIATED BY HUMAN GAB-1 PROTEIN
Authors: LEHR S KLEIN E KOTZKA J SIETHOFF C KNEBEL B KLEIN HW MEYER HE KRONE W MULLERWIELAND D
Citation: S. Lehr et al., SIGNALING SPECIFICITY OF INSULIN AND EGF MEDIATED BY HUMAN GAB-1 PROTEIN, Diabetes, 47, 1998, pp. 1274-1274
ADD1 SREBP-1C MEDIATES INSULIN-INDUCED GENE-EXPRESSION LINKED TO THE MAP KINASE PATHWAY/
Authors: KOTZKA J MULLERWIELAND D KOPONEN A NJAMEN D KREMER L ROTH G MUNCK M KNEBEL B KRONE W
Citation: J. Kotzka et al., ADD1 SREBP-1C MEDIATES INSULIN-INDUCED GENE-EXPRESSION LINKED TO THE MAP KINASE PATHWAY/, Biochemical and biophysical research communications (Print), 249(2), 1998, pp. 375-379
STABILIZATION OF ATHEROSCLEROTIC PLAQUE DURING LIPID-LOWERING
Authors: MULLERWIELAND D KOTZKA J KRONE W
Citation: D. Mullerwieland et al., STABILIZATION OF ATHEROSCLEROTIC PLAQUE DURING LIPID-LOWERING, Current opinion in lipidology, 8(6), 1997, pp. 348-353
DRUG-ACTION VIA GENE-TRANSCRIPTION - HMG-COA REDUCTASE INHIBITORS
Authors: MULLERWIELAND D KOTZKA J KRONE W
Citation: D. Mullerwieland et al., DRUG-ACTION VIA GENE-TRANSCRIPTION - HMG-COA REDUCTASE INHIBITORS, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 9-9
EFFECT OF A POINT MUTATION IN THE C-FOS GENE PROMOTER IN A PATIENT WITH INSULIN-RESISTANCE
Authors: AVCI H KOTZKA J KNEBEL B KRONE W MULLERWIELAND D
Citation: H. Avci et al., EFFECT OF A POINT MUTATION IN THE C-FOS GENE PROMOTER IN A PATIENT WITH INSULIN-RESISTANCE, Diabetes, 46, 1997, pp. 1094-1094
TYROSINE PHOSPHORYLATION OF RECOMBINANT HUMAN IRS-1 AND GAB-1 PROTEINDOMAINS BY INSULIN-RECEPTOR
Authors: LEHR S KLEIN E KOTZKA J KNEBEL B KLEIN H KRONE W MULLERWIELAND D
Citation: S. Lehr et al., TYROSINE PHOSPHORYLATION OF RECOMBINANT HUMAN IRS-1 AND GAB-1 PROTEINDOMAINS BY INSULIN-RECEPTOR, Diabetes, 46, 1997, pp. 1456-1456
DEFECTS OF INSULIN AND IGF-1 ACTION AT RECEPTOR AND POSTRECEPTOR LEVEL IN A PATIENT WITH TYPE-A SYNDROME OF INSULIN-RESISTANCE
Authors: KNEBEL B KELLNER S KOTZKA J SIEMEISTER G DREYER M STREICHER R SCHILLER M RUDIGER HW SEEMANOVA E KRONE W MULLERWIELAND D
Citation: B. Knebel et al., DEFECTS OF INSULIN AND IGF-1 ACTION AT RECEPTOR AND POSTRECEPTOR LEVEL IN A PATIENT WITH TYPE-A SYNDROME OF INSULIN-RESISTANCE, Biochemical and biophysical research communications, 234(3), 1997, pp. 626-630
SREBP-1 MEDIATES ACTIVATION OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR PROMOTER BY INSULIN AND INSULIN-LIKE GROWTH-FACTOR-I
Authors: STREICHER R KOTZKA J MULLERWIELAND D SIEMEISTER G MUNCK M AVCI H KRONE W
Citation: R. Streicher et al., SREBP-1 MEDIATES ACTIVATION OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR PROMOTER BY INSULIN AND INSULIN-LIKE GROWTH-FACTOR-I, The Journal of biological chemistry, 271(12), 1996, pp. 7128-7133
POSTRECEPTOR DEFECTS OF THE INSULIN-RECEPTOR (IR) FAMILY IN PATIENTS WITH GENETIC SYNDROMES OF INSULIN-RESISTANCE
Authors: MULLERWIELAND D KNEBEL B KOTZKA J AVCI H KRONE W
Citation: D. Mullerwieland et al., POSTRECEPTOR DEFECTS OF THE INSULIN-RECEPTOR (IR) FAMILY IN PATIENTS WITH GENETIC SYNDROMES OF INSULIN-RESISTANCE, Diabetes, 45, 1996, pp. 429-429
CHARACTERIZATION OF THE HUMAN APOPROTEIN CII GENE PROMOTOR AND ITS ALTERATION IN A PATIENT WITH CONGENITAL APO CII DEFICIENCY
Authors: AVCI H STREICHER R KOTZKA J MULLERWIELAND D GEISEL J WEISSHAAR C OETTE K KRONE W
Citation: H. Avci et al., CHARACTERIZATION OF THE HUMAN APOPROTEIN CII GENE PROMOTOR AND ITS ALTERATION IN A PATIENT WITH CONGENITAL APO CII DEFICIENCY, Circulation, 94(8), 1996, pp. 1588-1588
Risultati: 1-17 |